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UCM-UPM, Madrid, SpainAbstractThe analysis of microevolution events, its functional relevance and impact on molecular epidemiology strategies, constitutes one of the most
challenging aspects of the study of clonal complexity in infection by Mycobacterium tuberculosis. In this study, we retrospectively evaluated
whether two improved sampling schemes could provide access to the clonal complexity that is undetected by the current standards
(analysis of one isolate from one sputum). We evaluated in 48 patients the analysis by mycobacterial interspersed repetitive
unit–variable number tandem repeat of M. tuberculosis isolates cultured from bronchial aspirate (BAS) or bronchoalveolar lavage (BAL)
and, in another 16 cases, the analysis of a higher number of isolates from independent sputum samples. Analysis of the isolates from
BAS/BAL specimens revealed clonal complexity in a very high proportion of cases (5/48); in most of these cases, complexity was not
detected when the isolates from sputum samples were analysed. Systematic analysis of isolates from multiple sputum samples also
improved the detection of clonal complexity. We found coexisting clonal variants in two of 16 cases that would have gone undetected
in the analysis of the isolate from a single sputum specimen. Our results suggest that analysis of isolates from BAS/BAL specimens is
highly efﬁcient for recording the true clonal composition of M. tuberculosis in the lungs. When these samples are not available, we
recommend increasing the number of isolates from independent sputum specimens, because they might not harbour the same pool of
bacteria. Our data suggest that the degree of clonal complexity in tuberculosis has been underestimated because of the deﬁciencies
inherent in a simpliﬁed procedure.
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E-mail: dgviedma2@gmail.comIntroductionInfection by Mycobacterium tuberculosis is more clonally com-
plex than initially thought. Mixed infection by more than oneClinical Microbiology and Infection © 2014 European Society of CM. tuberculosis strain is the commonest form of clonal
complexity; coexistence of clonal variants in the same host is
the most unusual [1–3]. The emergence of clonal variants by
microevolution from a homogeneous parental bacterial pop-
ulation has been described at both intrapatient and inter-
patient levels [4–6]. These subtle changes have been
considered functionally signiﬁcant because they can affect the
ability of speciﬁc variants to infect respiratory/extra-
respiratory sites and macrophages, as well as their ability to
express genes in the regions where these variations map
[6–11].Clin Microbiol Infect 2015; 21: 147.e1–147.e7
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2014.09.015
147.e2 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIUntil recently, analysis of microevolution and identiﬁcation
of clonal variants could only be performed using standard
genotyping tools; therefore, variants were revealed only when
the genetic variations directly affected the regions or markers
used in the common ﬁngerprinting methods. The recent
introduction of whole genome sequencing has increased our
knowledge of the magnitude of the changes occurring in
strains as a result of microevolution and how it can impact on
the inference of tuberculosis transmission [12]. However,
improvements in the strategies applied to analyse microevo-
lution and clonal complexity have not been accompanied by a
parallel effort to improve sampling methods so that they can
provide a true picture of the composition of the population of
bacilli infecting a host. In fact, the standard sampling proce-
dure for ﬁngerprinting—analysis of only one M. tuberculosis
isolate from a single sputum specimen—has not been
extensively evaluated to ascertain whether it is efﬁcient
enough to record the true clonal composition of the
M. tuberculosis population infecting the lung [13]. In this study,
we evaluate the efﬁciency of two improved methods for
detecting clonal complexity in M. tuberculosis that might have
gone undetected using standard sampling procedures. The
two methods evaluated were analysis of higher-quality res-
piratory specimens (bronchial aspirate (BAS) or bron-
choalveolar lavage (BAL)), and analysis of a higher number of
isolates from sequential sputum specimens taken from the
same patient.Materials and methodsSelection of cases
In all cases, we retrospectively analysed drug-susceptible
M. tuberculosis strains that had been stored frozen since isola-
tion. For the analysis of higher-quality specimens we selected
cases with at least two M. tuberculosis isolates: one
M. tuberculosis isolate from a BAS or BAL specimen and another
M. tuberculosis isolate from sputum. For the analysis of isolates
from multiple sputum specimens, we selected cases with at
least four or more isolates from independent sputum speci-
mens taken early after diagnosis (less than 16 days).
We lacked the necessary data to establish the chronology for
samples corresponding to sequential extractions from 3 consec-
utive days that were received on the same day; therefore, we
considered these samples as though they were from a single day.
Cultures
Selected isolates were thawed, inoculated in mycobacterial
growth indicator tube liquid medium (Becton Dickinson,
Sparks, MD, USA), and incubated for 14 days at 37°C.Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InfectDNA puriﬁcation
DNA was extracted from 1 ml of culture using a column-based
puriﬁcation method and eluted in 100 μl of buffer AE (QIAamp
DNA minikit protocol, Qiagen, Courtaboeuf, France).
Screening of cases with clonally complex infections
As clonally complex infections, in this study we only considered
infections involving coexistence of clonal variants (those in
which we detected variants differing by one or two repetitions
in only one mycobacterial interspersed repetitive unit (MIRU)
locus) and not mixed infections.
Multiplex MIRU-VNTR analysis. Clonal variability was investigated
using mycobacterial interspersed repetitive unit–variable
number tandem repeat (MIRU-VNTR) (MIRU-24 multiplex
PCR format [14,15], as described in ref. [16]). PCR products
were analysed by capillary electrophoresis (3130xl Genetic
Analyzer, POP-7 polymer, 1200 LIZ ISS standard; Applied
Biosystems, Foster City, CA, USA). The PCR fragments were
sized using GeneMapper v4.0 [16].
We visually analysed the electropherograms generated by
GeneMapper for each multiplex PCR to ﬁnd minority peaks
indicating the presence of a second allelic variant for each of the
loci studied. Residual peaks corresponding to ﬂuorescence in-
tensity below 200 in height were not included.
Simplex MIRU-VNTR analysis. All cases of clonal complexity for a
locus in the multiplex MIRU-VNTR analysis in capillary elec-
trophoresis were conﬁrmed by repeating the analysis of the
locus using simplex MIRU-VNTR analysis and capillary elec-
trophoresis following procedures published elsewhere [14,15].
The cases in which we detected and conﬁrmed two variants
in the isolates after screening with MIRU-VNTR were recon-
ﬁrmed by identifying each of the variants independently in the
analysis of multiple single colonies after sub-culturing the
original isolate on agar plates. This was performed by means of
MIRU-VNTR analysis of the relevant locus by simplex PCR and
detection in agarose gel by standard electrophoresis (2% MS-8;
Pronadisa, Madrid, Spain) at 45 V for 18.5 h.ResultsAnalysis of clonal complexity in M. tuberculosis isolates
from BAL/BAS specimens
Our ﬁrst objective was to search for clonal complexity in cases
where M. tuberculosis was isolated from both BAL/BAS and
sputum samples to evaluate whether the deeper and more ho-
mogeneous sampling expected with BAL/BAS (considered for
this reason as a high-quality respiratory specimen) could provide
a more representative picture of clonal complexity than sputum.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 147.e1–147.e7
CMI Pérez-Lago et al. Revealing hidden clonal complexity in M. tuberculosis 147.e3We selected 48 patients from two different institutions for
whom M. tuberculosis had been isolated from a BAL or BAS
sample and a sputum sample in the same tuberculosis episode.
MIRU-VNTR analysis of the BAS/BAL isolates revealed ﬁve
(10.4%) cases in which two variants were observed according
to the double peaks detected in the electropherograms for the
loci MIRU42, MIRU26, 1995, MIRU40, and Q26 (Fig. 1a). All the
variations were single-locus variations; in three of these cases
the variants differed in one repetition, and in the two remaining
cases, the co-infecting variants differed in two repretitions. In all
ﬁve cases, the double peaks were conﬁrmed by simplex PCR of
the relevant locus; conﬁrmation was veriﬁed using analysis of
single colonies by MIRU-VNTR to reveal the presence of the
two variants. This analysis could be performed in four of the
ﬁve cases and enabled us to determine the relative proportion
between the two coexisting variants. The relative ratios for the
variants in patients 1, 3, 4 and 5 were 8 : 1, 50 : 1, 12 : 1 and 11 :
1, and, as expected, the variant with the highest allelic peak in
the electropherogram was the most abundant in the single-
colony analysis.
After detecting the ﬁve clonally complex cases, we performed
an equivalent analysis on the isolates recovered from the sputum
samples from the same ﬁve cases. In only one case, the two
variants detected in the isolate from the BAL specimen were
also detected in the isolate from sputum (case 5, Fig. 1b). In the
remaining four cases, only one of the variants detected in the
isolate from BAS/BAL was detected in sputum (Fig. 1b). Sur-
prisingly, in two of these cases (1 and 4), the variant detected in
sputum was the least frequent in BAS/BAL (Fig. 1a, b).
Our ﬁndings indicated that in most of the cases shown to be
clonally complex after analysis of BAL/BAS, analysis of a single
sputum sample did not reveal complexity. We therefore evalu-
ated whether this deﬁciency could be compensated by increasing
the number of sputum specimens analysed. Unfortunately, we
only had additional isolates from independent specimens for one
of the ﬁve cases (two additional sputum specimens for case 1,
collected 3 and 6 days before the BAL isolate). In one of the
additional sputum specimens we again detected the same single
variant as in the previous specimen (Fig. 1c); however, in the other
specimen, we detected the second variant, namely, the one that
had been detected in the isolate from BAL. For case 1, the clonal
complexity detected in a single isolate fromBALwas also detected
when analysing the isolates from sputum; however, it was
necessary to analyse the isolates from three specimens, because
none of them simultaneously harboured the two variants.
Analysis of clonal complexity in multiple sputum
samples
The ﬁndings reported above suggest that increasing the number
of isolates from sputum samples could compensate for theClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Inlimitations of analysing the isolate from a single sputum spec-
imen to reveal the clonal complexity detected in BAL/BAS.
Therefore, to ﬁnd an alternative improved procedure for the
cases in which BAS/BAL specimens were not accessible, we
evaluated whether more systematic screening of specimens
from a new selection of patients could also reveal clonal
complexity that may have gone undetected using the standard
one-sputum-sampling procedures.
We selected a population of patients with four or more
M. tuberculosis isolates from independent sputum samples
collected early after diagnosis (within the ﬁrst 16 days). We
analysed 79 samples from 16 patients. For each case, we used
MIRU-VNTR for screening, starting with the ﬁrst diagnostic
sample and continuing until clonal complexity was detected.
Clonal complexity was detected in two cases (12.5%; patients
M4 and M15) (Fig. 2a). In patient M4, we analysed six
M. tuberculosis isolates from sputum sampled on days 0 and 7.
Five isolates showed the same allelic value in the ETRA locus
(three repetitions), whereas the remaining sample showed a
two-repetition variant. For patient M15, after analysing the
isolates from three samples, all from day 0, we found one
showing clonal complexity. In this case, 1 isolate simulta-
neously harboured two clonal variants, differing in one single-
locus variant (three and four repetitions) in the MIRU16 locus,
whereas the remaining two harboured only the four-
repetition variant (Fig. 2b). In both cases (patients M4 and
M15), the presence of the two variants was conﬁrmed by
simplex PCR of the relevant locus. In patient M15, the original
isolate was sub-cultured on agar to analyse multiple indepen-
dent colonies, showing the allele 3 variant to be a minority
variant (1:5).
To conﬁrm the presence of the clonal variants identiﬁed in
patients M4 and M15 during the remainder of the infection, we
analysed the subsequent available samples from both patients
using the same MIRU-VNTR analysis, which was now
restricted to the relevant loci. For patient M4, we collected
four additional isolates on days 17 and 30. We found that one
of the isolates from day 30 showed the two previously
detected variants in ETRA and a third additional variant (allelic
value 4, Fig. 2b); all three were detected simultaneously in the
same isolate. The original isolate was sub-cultured on agar;
variants corresponding to alleles 2 and 3 were conﬁrmed (1 :
1). The allele 4 variant was not detected after analysing 40
single colonies, suggesting that it was under-represented. Pa-
tient M15 had two isolates sampled on day 16 available for
analysis. In one isolate, the coexistence of the allele 3 and 4
variants observed in MIRU16 on day 0 was also conﬁrmed,
whereas the other isolate from the same day only showed the
allele 4 variant (Fig. 2b).fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 147.e1–147.e7
FIG. 1. Representation of the electropherograms (each peak corresponds to a mycobacterial interspersed repetitive unit–variable number tandem repeat (MIRU-VNTR) ampliﬁcation product, its height
corresponds to ﬂuorescence intensity and its position in the x-axis indicates its size in bp) corresponding to the MIRU-VNTR loci showing clonal complexity in patients 1 to 5. The result for the MIRU loci
involved in clonal heterogeneity is the only one shown (MIRU locus indicated under each graph). The results are shown according to origin: (a) isolates from bronchial aspirate (BAS) or bronchoalveolar
lavage (BAL); (b) isolates from a sputum specimen from the cases in (a); and (c) isolates from two additional sputum specimens for patient 1. The allelic values for the peaks are indicated in boxes. The
MIRU-VNTR pattern is shown under each graph with the allelic differences between the co-infecting variants highlighted in bold. The relative proportion between the two variants is indicated by the ratio
at the right side of the MIRU-VNTR pattern.
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FIG. 2. Representation of the electropherograms (each peak correspond to a mycobacterial interspersed repetitive unit–variable number tandem
repeat (MIRU-VNTR) ampliﬁcation product, its height corresponds to ﬂuorescence intensity and its position in the x-axis indicates its size in bp)
corresponding to the MIRU-VNTR loci showing clonal complexity in patients M4 and M15. The result for the MIRU loci involved in clonal hetero-
geneity is the only one shown (the cases and the MIRU loci involved are indicated at the left side of the ﬁgure). (a) Patterns supporting the identiﬁcation
of clonal complexity close to the time of diagnosis. The number of specimens in which each pattern was detected is indicated above each graph. (b)
Analysis of additional specimens to conﬁrm the permanence of the clonal complexity detected in (a). The allelic values are indicated in boxes. The
MIRU pattern is shown under each graph with the allelic differences between the co-infecting variants highlighted in bold.
CMI Pérez-Lago et al. Revealing hidden clonal complexity in M. tuberculosis 147.e5DiscussionMajor advances have been made in the study of clonal
complexity in M. tuberculosis infection. The ﬁndings of several
studies have highlighted the extent of this phenomenon in a
variety of settings. Microevolution leading to the emergence of
clonal variants has been described at both intrapatient and
interpatient levels [3–6], and cut-offs for tolerance of micro-
evolution within clusters have been proposed [17].
However, the advances made in this area overshadow, to a
certain extent, the evaluation of whether standard diagnostic
sampling procedures are also valid for determining the true
clonal composition of the bacterial population infecting the
lungs of patients with tuberculosis. In most studies that address
clonal complexity and microevolution, ﬁngerprinting is per-
formed using an M. tuberculosis isolate cultured from a single
sputum specimen; therefore, we may be underestimating the
clonal complexity of tuberculosis because our sampling pro-
cedures are too simple. Moreover, it may be naive to assume
that a single isolate from one sample could provide a true
picture of clonal composition in the respiratory compartment.
Some studies have found that different sputum samples from
the same patient lead to the isolation of different variants [3,13].Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and InSince autopsy-based evidence has shown that different clones
could be located at different lung sites [18], the composition of
bacteria in sputum specimens from the same patient could
differ. In addition, microevolution leading to the emergence of
clonal variants seems to be a highly dynamic process with in-
teractions, even competition, between the variants, before one
or more are evolutionarily ﬁxed [12]. Consequently, the
snapshot provided by a single sputum specimen may not be a
reliable representation of true clonal complexity.
We attempted to complete this area of research by evalu-
ating the procedure we use to analyse clonal complexity in
M. tuberculosis. Our data indicated that standard approaches
actually underestimate the true proportion of clonal complexity
in tuberculosis; therefore, we suggest alternative procedures to
improve the efﬁciency of our detection strategies. Sampling
isolates from BAS/BAL revealed a much higher percentage of
clonally complex cases than in previous studies based on sam-
pling from sputum [3,6,13]. In addition, the clonal complexity
we found in BAS/BAL could also be detected using the standard
sampling from sputum in only one of the ﬁve cases. Of note, in
the only case with a higher number of sputum samples available,
none had revealed the coexistence of two variants, although
they were identiﬁed in independent isolates from independent
sputum specimens. Alternatively, increasing the number offectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 147.e1–147.e7
147.e6 Clinical Microbiology and Infection, Volume 21 Number 2, February 2015 CMIisolates from different sputum specimens led to a much higher
percentage of clonally complex cases than the standard
approach. In studies by our group based on standard sampling
approaches, a systematic survey showed that the percentage of
cases with coexistence of clonal variants (1.6%) was clearly
below current ﬁgures [3].
It seems clear, therefore, that the true proportion of clonal
complexity in M. tuberculosis infection will remain under-
estimated until sampling procedures improve. Nevertheless,
our secondary ﬁndings emphasise the limitations and unpre-
dictability of sputum sampling for determining the true
composition of the expected bacterial population in the respi-
ratory compartment. For example, when the variants in BAL/
BAS were compared with the variant detected in sputum in a
patient with clonally complex M. tuberculosis infection, the
variant in sputum was not always over-represented in BAL/BAS
and may even be the minority variant.
The expected variability in a single sputum sample is also
illustrated by the ﬁnding that in the two clonally complex cases,
most specimens had a single genotype. The second co-infecting
variant was only detected in two of ten specimens from patient
M4 and in two of ﬁve from patient M15. It is noteworthy that
heterogeneity in these infections is not a short and transient
ﬁnding, because it was detected in chronologically separated
specimens. The fact that variants are observed at different
points during the chronology of infection conﬁrmed the pres-
ence of co-infecting variants and suggested that if they are not
detected, it is because of the inability of a single sputum
specimen to represent the whole bacterial population. There-
fore, the observation window should be extended to minimise
the risk of overlooking clonal complexity in M. tuberculosis
infection. The presence of co-infecting clonal variants at
different points during heterogeneous infection is consistent
with the functional role underlying this variability. Several au-
thors suggest that the variations generated by microevolution
can affect expression of neighbouring genes [6–10], the ability
of the variants to replicate in macrophages [11], and the
infective behaviour of the variants in the clinical setting [19,20].
The MIRU loci involved in the acquisition of variability detected
in this study are located in genomic contexts where the vari-
ation in the number of repetitions could have a potential
functional effect. In some loci (MIRU42, MIRU26, 1955,
MIRU40, Q26 and MIRU16), this variation can affect the
expression of adjacent genes, and in others (ETRA, located in
the Rv1917 (PPE34) gene), it could affect the antigenic prop-
erties of the coded protein [21]. The detection of these vari-
ants indicates that they were ﬁxed after their emergence and
that the subtle changes they underwent must therefore be
advantageous for the strains. In the perspective of patient
management, it is relevant to assure a high efﬁciency to detectClinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectthe true composition of clonal variants co-infecting the same
patient because infectivity, virulence or ability to acquire mu-
tations and therefore resistances are all features that could be
modulated by the emergence of certain subtle genetic changes
from a parental strain.
Improving the detection of microevolution events it is also
essential to assure precision in the identiﬁcation of recent
transmission events. The deﬁnition of a cluster lies on the
detection of identical ﬁngerprints between two or more
cases in a population. The high genetic intra-patient vari-
ability in the M. tuberculosis population in the lung, recorded
by BAS/BAL samples (10.4%), and the different clonal
composition observed between the different isolates from
different sputum specimens from the same patient, could
impact on the ﬁnal ﬁngerprint assigned to a case and,
therefore to the correct identiﬁcation of recent transmission
events. Only the precise identiﬁcation of the genotypic
variability in the M. tuberculosis isolate from a patient can
assure precision in tuberculosis control programmes sup-
ported by molecular epidemiology strategies.
In summary, detection of clonal variants of M. tuberculosis co-
infecting a single host seems to be more challenging than initially
assumed. The highly dynamic events involved in microevolution,
the interactions and potential competition between variants,
and the differences in representativeness between variants
indicate that standard sampling based on ﬁngerprinting of a
single isolate cultured from one sputum sample is more likely
underestimate the true proportion of clonal complexity in
tuberculosis. Our data suggest that more clonally complex
events can be detected using higher-quality respiratory speci-
mens, such as BAL or BAS. When these specimens are not
accessible, we recommend increasing the number of sputum
samples. Every effort should be made to improve sampling
procedures to gain access to the as yet undiscovered pool of
clonal complexity in tuberculosis and so better understand its
signiﬁcance and its impact on the interpretation of clusters and
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